Skip to main content

Dyadic International Inc

DYAI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001213809

In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Dyadic International Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of DYAI: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders4948−1
Shares5.39M4.05M−1.33M (−24.8%)
Value$29.6M$14.5M−$15.0M (−50.8%)

New holders (15)

Institutions that held Dyadic International Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to DYAI in Q2 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC268,447$964.0K0.00%
Tibra Equities Europe Ltd82,400$296.0K0.09%
Ergoteles LLC80,841$290.0K0.01%
HRT Financial LP54,700$196.0K0.00%
Walleye Capital LLC35,745$128.0K0.00%
Commonwealth Equity Services, LLC19,512$70.0K0.00%
Equitable Holdings, Inc.19,250$69.0K0.00%
Walleye Trading LLC19,159$69.0K0.00%
Jane Street Group, LLC16,071$58.0K0.00%
Jump Financial, LLC12,100$43.0K0.00%
LMR Partners LLP10,110$36.0K0.00%
Aristides Capital LLC10,000$36.0K0.03%
Monticello Wealth Management, LLC10,000$36.0K0.00%
Cutler Group LP200$00.00%
Quadrant Capital Group LLC136$00.00%

Sold out (16)

Institutions that held Dyadic International Inc at the end of Q1 2021 and filed for Q2 2021 without it.